查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1318706

龐貝氏症市場：依治療類型（酵素、基材）、分子類型（生物製品、小分子）、劑型、給藥途徑- 全球預測 2023-2030

Pompe Disease Market by Therapy Type (Enzyme, Substrate), Molecule Type (Biologics, Small Molecules), Dosage Form, Route of Administration - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2023 年，全球龐貝氏症市場將達到 15.0906 億美元，年複合成長率為 5.59%，預計到 2030 年將出現驚人成長，達到 22.118 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球龐貝氏症市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.龐貝氏症全球市場規模及預測是多少？

2.在預測期內，COVID-19 影響全球龐貝氏症市場的阻礙因素和影響為何？

3.全球龐貝氏症市場預測期間有哪些產品/細分市場/應用/領域值得投資？

4.全球龐貝氏症市場的競爭策略為何？

5. 龐貝氏症全球市場的技術趨勢和法律規範是什麼？

6.全球龐貝氏症市場主要供應商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入龐貝氏症全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 龐貝氏症的普及正在增加
      • 長期治療的採用以及診斷和治療的進步
      • 基因療法和酵素替代療法的開發取得進展
    • 抑制因素
      • 龐貝氏症治療費用昂貴
    • 機會
      • 加大研發投入
      • 政府致力於開發和製造創新產品
    • 任務
      • 治療意識淡薄
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 龐貝氏症市場（依治療類型）

  • 酵素
  • 基板

第7章 按分子類型分類的龐貝病市場

  • 生物製品
  • 低分子

第8章 龐貝氏症市場（按劑型）

  • 液體
  • 個人

第9章 龐貝氏症市場：依給藥途徑

  • 口服
  • 家長

第10章 美洲龐貝氏症市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太龐貝氏症市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東及非洲龐貝氏症市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-035AB9C0DAD2

The Global Pompe Disease Market is forecasted to grow significantly, with a projected USD 1,509.06 million in 2023 at a CAGR of 5.59% and expected to reach a staggering USD 2,211.80 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pompe Disease Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pompe Disease Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Therapy Type, market is studied across Enzyme and Substrate. The Substrate is projected to witness significant market share during forecast period.

Based on Molecule Type, market is studied across Biologics and Small Molecules. The Biologics is projected to witness significant market share during forecast period.

Based on Dosage Form, market is studied across Liquid and Solid. The Solid is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Oral and Parental. The Parental is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pompe Disease Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pompe Disease Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pompe Disease Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pompe Disease Market?

4. What is the competitive strategic window for opportunities in the Global Pompe Disease Market?

5. What are the technology trends and regulatory frameworks in the Global Pompe Disease Market?

6. What is the market share of the leading vendors in the Global Pompe Disease Market?

7. What modes and strategic moves are considered suitable for entering the Global Pompe Disease Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Pompe Disease Market, by Therapy Type, 2022 vs 2030
  • 4.3. Pompe Disease Market, by Molecule Type, 2022 vs 2030
  • 4.4. Pompe Disease Market, by Dosage Form, 2022 vs 2030
  • 4.5. Pompe Disease Market, by Route of Administration, 2022 vs 2030
  • 4.6. Pompe Disease Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of pompe disease
      • 5.1.1.2. Uptake of long term therapies and advancement in the diagnosis and treatment
      • 5.1.1.3. Increasing developments in the gene therapy and enzyme replacement therapies
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment costs of pompe diseases
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in the research and development
      • 5.1.3.2. Government initiatives for the development and manufacture of innovative products
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about the treatment
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Pompe Disease Market, by Therapy Type

  • 6.1. Introduction
  • 6.2. Enzyme
  • 6.3. Substrate

7. Pompe Disease Market, by Molecule Type

  • 7.1. Introduction
  • 7.2. Biologics
  • 7.3. Small Molecules

8. Pompe Disease Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Solid

9. Pompe Disease Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Oral
  • 9.3. Parental

10. Americas Pompe Disease Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pompe Disease Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pompe Disease Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. POMPE DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. POMPE DISEASE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. POMPE DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2022 VS 2030 (%)
  • FIGURE 6. POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2022 VS 2030 (%)
  • FIGURE 7. POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • FIGURE 8. POMPE DISEASE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. POMPE DISEASE MARKET DYNAMICS
  • FIGURE 10. POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. POMPE DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. POMPE DISEASE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. POMPE DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. POMPE DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. POMPE DISEASE MARKET SIZE, BY ENZYME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. POMPE DISEASE MARKET SIZE, BY SUBSTRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. POMPE DISEASE MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 11. POMPE DISEASE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. POMPE DISEASE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 14. POMPE DISEASE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. POMPE DISEASE MARKET SIZE, BY PARENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. SINGAPORE POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. SINGAPORE POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. TAIWAN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. THAILAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. THAILAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. VIETNAM POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. VIETNAM POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. DENMARK POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. DENMARK POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. EGYPT POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EGYPT POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. FINLAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. FINLAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. FRANCE POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FRANCE POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. GERMANY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. GERMANY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. ISRAEL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. ISRAEL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. ITALY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ITALY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. NETHERLANDS POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. NETHERLANDS POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. NIGERIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NIGERIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. NORWAY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NORWAY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. POLAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. POLAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. QATAR POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. QATAR POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. RUSSIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. RUSSIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. SPAIN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SPAIN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. SWEDEN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SWEDEN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. SWITZERLAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWITZERLAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. TURKEY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TURKEY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. POMPE DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 185. POMPE DISEASE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 186. POMPE DISEASE MARKET LICENSE & PRICING